A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC

Clinical trial NCT02106494 · COMPLETED

Trial details

NCT number: NCT02106494
Sponsor: Heron Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting

Start date: 2014-03-01
Primary completion: 2015-05-01
Enrollment: 942

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.